Nebulisers ruled out for bronchiolitis in children

GPs should not use nebulisers in the treatment of bronchiolitis in children, according to guidance from SIGN.

This is the first clinical guidance of its kind in the UK. It was issued in preparation for the winter months where there is a peak prevalence of bronchiolitis.

Despite 2 per cent of all UK infants being admitted to hospital with bronchiolitis, no guidelines have been made available for treatment until now.

The SIGN guidance states that nebulised ribavirin, nebulised ipratropium and nebulised epinephrine should not be used for the treatment of infants with acute bronchiolitis. Antibiotic therapy and inhaled beta 2 agonist bronchodilators are not recommended for treatment either.

The routine use of palivizumab is not recommended but may be considered for use on a case-by-case basis in infants, less than 12 months old, with extreme prematurity or immune deficiency.

Somerset GP Dr Steve Holmes, chairman of the General Practice Airways Group, said: 'It is nice to see a review of the bronchiolitis literature that clears up the issues of whether to use nebulisers for the treatment of bronchiolitis.'

Consultant respiratory paediatrician Dr Steve Cunningham, chairman of the SIGN bronchiolitis guideline group, said that the guidelines would provide the latest evidence-driven guidance that GPs could use.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Dr Vasumathy Sivarajasingam explains why screening for domestic abuse should be standard...

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...